BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| (2S)-2-amino-4-carbamoylbutanoic acid {Glutamine} - Clostridium septicum |
👶
Low-protein diet supplemented with 1% L-glutamine improves growth performance, serum biochemistry, redox status, plasma amino acids, and alters fecal microbiota in weaned piglets. Animal nutrition (Zhongguo xu mu shou yi xue hui) (Anim Nutr ) Vol: 17 Issue Pages: 144-154 Pub: 2024 Jun Epub: 2024 Feb 3 Authors Li J , Bai J , Yang Y , Wu Z , Html Article Publication |
| (2S)-2-amino-4-carbamoylbutanoic acid {Glutamine} - Clostridium septicum |
👶
Dietary glycyl-glutamine supplementation ameliorates intestinal integrity, inflammatory response, and oxidative status in association with the gut microbiota in LPS-challenged piglets. Food & function (Food Funct ) Vol: 12 Issue 8 Pages: 3539-3551 Pub: 2021 Apr 21 Epub: 2021 Mar 29 Authors Xu B , Yan Y , Yin B , Zhang L , Qin W , Niu Y , Tang Y , Zhou S , Yan X , Ma L , Publication |
| (2S)-2-amino-4-carbamoylbutanoic acid {Glutamine} - Clostridium septicum |
👶
Effect of dietary supplementation with glutamine and a combination of glutamine-arginine on intestinal health in twenty-five-day-old weaned rabbits. Journal of animal science (J Anim Sci ) Vol: 88 Issue 1 Pages: 170-80 Pub: 2010 Jan Epub: 2009 Sep 25 Authors Chamorro S , de Blas C , Grant G , Badiola I , Menoyo D , Carabaño R , Publication |
| (2S)-2-amino-4-carbamoylbutanoic acid {Glutamine} - Clostridium septicum |
👶
Effects of Dietary Glutamine Supplementation on the Modulation of Microbiota and Th17/Treg Immune Response Signaling Pathway in Piglets after Lipopolysaccharide Challenge. The Journal of nutrition (J Nutr ) Vol: 154 Issue 5 Pages: 1711-1721 Pub: 2024 May Epub: 2024 Feb 16 Authors Liu G , Liu X , Wang F , Jia G , Zhao H , Chen X , Wang J , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
